ConvaTec Group PLC
F:2CV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
ConvaTec Group PLC
F:2CV
|
UK |
|
P
|
Pacira Biosciences Inc
SWB:82P
|
US |
|
M
|
Macy's Inc
LSE:0JXD
|
US |
|
I
|
International Flavors & Fragrances Inc
XETRA:IFF
|
US |
|
C
|
China Construction Bank Corp
OTC:CICHY
|
CN |
|
T
|
TCL Electronics Holdings Ltd
OTC:TCLHF
|
CN |
|
B
|
Bankinter SA
SWB:BAKA
|
ES |
|
Fuelcell Energy Inc
XETRA:FEY
|
US |
|
S
|
Shiseido Co Ltd
XBER:SHD
|
JP |
|
A
|
Atmos Energy Corp
SWB:AEO
|
US |
|
B
|
Best Buy Co Inc
XMUN:BUY
|
US |
|
D
|
Draganfly Inc
NASDAQ:DPRO
|
CA |
|
C
|
Compagnie de Saint Gobain SA
PAR:SGONV
|
FR |
ConvaTec Group PLC
ConvaTec Group PLC makes medical products used to care for people with long-term or chronic conditions. Its main products include ostomy bags and accessories, wound dressings, continence care products, and other skin and catheter-related items. These are everyday care items that help patients manage conditions at home, in hospitals, and in care facilities. The company sells mainly to hospitals, clinics, healthcare providers, distributors, and patients. It makes money by selling branded consumable products that need to be replaced regularly, so customers come back again and again. A lot of its business also depends on doctors, nurses, and care teams recommending the right products for each patient. What makes ConvaTec different is that it sits in the middle of long-term patient care rather than one-time procedures. Its products are less about curing disease and more about helping people live with it comfortably and safely. That gives the company a steady role in the healthcare supply chain and ties its business closely to ongoing medical need.
ConvaTec Group PLC makes medical products used to care for people with long-term or chronic conditions. Its main products include ostomy bags and accessories, wound dressings, continence care products, and other skin and catheter-related items. These are everyday care items that help patients manage conditions at home, in hospitals, and in care facilities.
The company sells mainly to hospitals, clinics, healthcare providers, distributors, and patients. It makes money by selling branded consumable products that need to be replaced regularly, so customers come back again and again. A lot of its business also depends on doctors, nurses, and care teams recommending the right products for each patient.
What makes ConvaTec different is that it sits in the middle of long-term patient care rather than one-time procedures. Its products are less about curing disease and more about helping people live with it comfortably and safely. That gives the company a steady role in the healthcare supply chain and ties its business closely to ongoing medical need.
Strong Sales Growth: ConvaTec delivered 8% constant currency growth and 6.4% organic revenue growth in the first half of 2022, with all four categories contributing.
Margins Hold Up: EBIT margin was 19.6%, stable year-on-year despite inflation and higher investment in R&D and sales/marketing.
Guidance Unchanged: Management reaffirmed full-year guidance for 4%–5.5% organic sales growth and at least 18% EBIT margin (constant currency), despite increased cost pressures.
Operational Efficiency: Ongoing focus on simplification and efficiency led to G&A expenses dropping below 10% of sales for the first time.
Strong Cash Generation: Robust cash flow enabled continued investment in growth, including $179 million in M&A during H1.
Product Pipeline: New product launches and acquisitions (e.g., Triad Life Sciences) are expected to support future growth and margin improvement.
Supply Chain Resilience: Management reported a stronger and more resilient supply chain, aided by increased inventory and automation investments.
Mid-Term Margin Ambition: Leadership reiterated confidence in growing EBIT margin to the mid-20% range over time.
